Alar Batten Graft vs Latera for Nasal Valve Collapse
NCT03793218 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2024-01-11
Summary
Nasal obstruction is a common complaint for the patient presenting to the Otolaryngologist and/or the Facial Plastic surgeon. There are numerous potential causes of nasal obstruction, with more easily addressed pathologies such as posterior septal deviation and inferior turbinate hypertrophy often being over-diagnosed. Nasal valve obstruction, particularly dynamic nasal sidewall collapse, is of significant interest to the rhinoplasty surgeon. Traditionally, collapse of the nasal sidewall has been addressed via structural cartilage grafting, with alar batten grafting being the most commonly used method to provide support to the weak nasal sidewall. Recently, an absorbable nasal implant, comprised of a polylactic acid copolymer, has been advocated for supporting the nasal sidewall and relieving nasal obstruction. There are several proposed advantages of the implant over traditional operative techniques, namely the ease of endonasal insertion, which can be performed in the outpatient clinic setting. Preliminary investigations demonstrate subjective improvement in nasal obstruction with use of the implant, however, there has been no direct comparison with traditional techniques utilizing cartilage grafting.
This study is being done at both UVa and in Oregon. This prospective study will randomize patients with nasal obstruction and documented dynamic nasal sidewall collapse into one of two groups undergoing treatment with either endonasal batten grafting or the absorbable Latera nasal valve implant. Preoperative and postoperative nasal obstruction will be assessed with a validated survey for nasal obstructive symptoms, the Nasal Obstruction Symptom Evaluation (NOSE) score. The mean preoperative and postoperative NOSE score between the groups will be compared at 1, 6, 12, and 24 months post-operatively to compare the efficacy of both techniques. Subjects will be blinded to the surgical intervention they receive.
Conditions
- Nasal Valve Incompetence
Interventions
- DEVICE
-
Latera Device
This study seeks to compare a "gold standard" functional rhinoplasty maneuver, the alar batten graft, to the LATERA implant
- PROCEDURE
-
Alar Batten Graft
This study seeks to compare a "gold standard" functional rhinoplasty maneuver, the alar batten graft, to the LATERA implant
Sponsors & Collaborators
-
Portland VA Medical Center
collaborator FED -
University of Virginia
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-28
- Primary Completion
- 2019-09-01
- Completion
- 2019-09-01
More Related Trials
-
Nickel Allergy With Septal Closure Devices
NCT01068366 ·Status: TERMINATED
-
AltaValve Pivotal Trial
NCT06465745 ·Status: RECRUITING ·Phase: NA
-
Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
NCT00572091 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Left Atrial and Pulmonary Vein Transplant for Pulmonary Vein Stenosis
NCT03456193 ·Status: SUSPENDED ·Phase: NA
-
Laryngeal Pacing Study
NCT03085316 ·Status: TERMINATED ·Phase: NA
-
Observational Study of the Heart Repair Technologies Mitral Bridge in Treating Mitral Valve Regurgitation
NCT03511716 ·Status: TERMINATED
-
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
NCT02205411 ·Status: TERMINATED ·Phase: NA
-
Influence of Right Ventricular Function on Changes in Exercise Capacity After LVAD
NCT05916612 ·Status: WITHDRAWN
-
Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation
NCT04666480 ·Status: TERMINATED ·Phase: NA
-
Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
NCT06634121 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure
NCT00815386 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
LVAD in Non Cardiac Transplant Candidates and Non Responders to Resynchronization
NCT01126944 ·Status: WITHDRAWN ·Phase: NA
-
Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study
NCT00647387 ·Status: COMPLETED ·Phase: NA
-
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
NCT02790242 ·Status: TERMINATED
-
NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation
NCT03015194 ·Status: COMPLETED ·Phase: NA
-
On-X Heart Valve - 17mm Aortic and 23mm Mitral
NCT01812174 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
NCT00568230 ·Status: COMPLETED ·Phase: PHASE1
-
Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation
NCT04098328 ·Status: TERMINATED
-
ALTERRA Post-Approval Study
NCT05378386 ·Status: ACTIVE_NOT_RECRUITING
-
Twelve Transcatheter Mitral Valve Replacement (TMVR) Pilot Study
NCT02428010 ·Status: TERMINATED ·Phase: NA
-
Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure
NCT01512381 ·Status: TERMINATED ·Phase: PHASE4
-
Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD
NCT04458103 ·Status: TERMINATED ·Phase: NA
-
A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System
NCT05417945 ·Status: UNKNOWN ·Phase: NA
-
AltaValve Early Feasibility Study Protocol
NCT03997305 ·Status: UNKNOWN ·Phase: NA
-
Positive Airway Pressure Therapy Study in Sleep Apnea and Diastolic Heart Failure
NCT02254382 ·Status: TERMINATED ·Phase: NA